Kun-Hsing Yu, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Computational Biology | 7 | 2022 | 3505 | 0.970 |
Why?
|
Platinum | 1 | 2020 | 223 | 0.650 |
Why?
|
Platinum Compounds | 1 | 2016 | 95 | 0.520 |
Why?
|
Bronchopulmonary Dysplasia | 2 | 2016 | 316 | 0.500 |
Why?
|
Data Mining | 2 | 2018 | 553 | 0.500 |
Why?
|
Lung Neoplasms | 5 | 2020 | 13262 | 0.490 |
Why?
|
Tuberous Sclerosis | 2 | 2020 | 1030 | 0.460 |
Why?
|
Artificial Intelligence | 2 | 2018 | 2557 | 0.460 |
Why?
|
Rare Diseases | 1 | 2019 | 619 | 0.450 |
Why?
|
Proteomics | 5 | 2018 | 3817 | 0.440 |
Why?
|
Ovarian Neoplasms | 3 | 2020 | 4878 | 0.420 |
Why?
|
Proteome | 3 | 2018 | 1855 | 0.420 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2020 | 4024 | 0.420 |
Why?
|
Lymphatic Metastasis | 1 | 2020 | 2943 | 0.410 |
Why?
|
Metabolomics | 2 | 2018 | 1628 | 0.390 |
Why?
|
United States Food and Drug Administration | 1 | 2019 | 1677 | 0.370 |
Why?
|
Adenocarcinoma | 3 | 2017 | 6315 | 0.360 |
Why?
|
Delivery of Health Care | 2 | 2018 | 5325 | 0.360 |
Why?
|
Decision Support Techniques | 1 | 2020 | 2001 | 0.360 |
Why?
|
Lung | 3 | 2017 | 9994 | 0.340 |
Why?
|
Neoplasm Proteins | 3 | 2016 | 3610 | 0.330 |
Why?
|
Decision Support Systems, Clinical | 1 | 2018 | 1164 | 0.330 |
Why?
|
Lymph Nodes | 1 | 2020 | 3486 | 0.320 |
Why?
|
Neoplasm Staging | 2 | 2021 | 11152 | 0.320 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3696 | 0.290 |
Why?
|
Clinical Trials as Topic | 2 | 2021 | 8056 | 0.280 |
Why?
|
Search Engine | 2 | 2018 | 140 | 0.280 |
Why?
|
Psychotic Disorders | 1 | 2022 | 3193 | 0.280 |
Why?
|
Carcinoma, Renal Cell | 1 | 2021 | 3218 | 0.260 |
Why?
|
Twins, Dizygotic | 2 | 2016 | 236 | 0.250 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4312 | 0.230 |
Why?
|
Twins, Monozygotic | 2 | 2016 | 469 | 0.230 |
Why?
|
ROC Curve | 3 | 2021 | 3568 | 0.220 |
Why?
|
Schizophrenia | 1 | 2022 | 6915 | 0.220 |
Why?
|
Neoplasms | 4 | 2021 | 22072 | 0.220 |
Why?
|
Prognosis | 8 | 2022 | 29658 | 0.210 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5251 | 0.190 |
Why?
|
Models, Biological | 1 | 2017 | 9467 | 0.190 |
Why?
|
Labor, Induced | 1 | 2021 | 151 | 0.180 |
Why?
|
Humans | 40 | 2022 | 760621 | 0.180 |
Why?
|
Area Under Curve | 2 | 2022 | 1636 | 0.170 |
Why?
|
Professional Competence | 2 | 2014 | 431 | 0.170 |
Why?
|
Thyrotropin | 1 | 2021 | 832 | 0.150 |
Why?
|
Drug Eruptions | 1 | 2021 | 335 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12293 | 0.150 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2021 | 8950 | 0.150 |
Why?
|
Human Genome Project | 1 | 2018 | 199 | 0.150 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2017 | 146 | 0.140 |
Why?
|
Cell Dedifferentiation | 1 | 2017 | 122 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 1 | 2020 | 20509 | 0.140 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2022 | 1088 | 0.140 |
Why?
|
Twin Studies as Topic | 1 | 2016 | 104 | 0.130 |
Why?
|
Exanthema | 1 | 2021 | 504 | 0.130 |
Why?
|
Quality Control | 1 | 2018 | 828 | 0.130 |
Why?
|
Mutation | 2 | 2021 | 29932 | 0.130 |
Why?
|
Comorbidity | 2 | 2022 | 10551 | 0.130 |
Why?
|
Cultural Characteristics | 2 | 2014 | 253 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 2 | 2016 | 17790 | 0.120 |
Why?
|
Students, Nursing | 1 | 2014 | 45 | 0.110 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 194 | 0.110 |
Why?
|
Algorithms | 3 | 2020 | 13981 | 0.110 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2016 | 406 | 0.110 |
Why?
|
Patient Admission | 1 | 2021 | 1386 | 0.110 |
Why?
|
Birth Weight | 1 | 2021 | 2097 | 0.110 |
Why?
|
Thiazolidinediones | 1 | 2016 | 465 | 0.110 |
Why?
|
Social Values | 1 | 2014 | 225 | 0.110 |
Why?
|
Tacrolimus | 1 | 2016 | 733 | 0.100 |
Why?
|
Female | 18 | 2022 | 391270 | 0.100 |
Why?
|
Pathology, Clinical | 1 | 2016 | 375 | 0.100 |
Why?
|
Lymphoma | 1 | 2021 | 1898 | 0.100 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2016 | 479 | 0.100 |
Why?
|
Morphogenesis | 1 | 2015 | 740 | 0.100 |
Why?
|
Databases, Protein | 1 | 2013 | 388 | 0.100 |
Why?
|
Autistic Disorder | 1 | 2020 | 1216 | 0.090 |
Why?
|
Middle Aged | 10 | 2021 | 220352 | 0.090 |
Why?
|
Infant, Newborn | 4 | 2020 | 26181 | 0.090 |
Why?
|
Brain Neoplasms | 2 | 2022 | 8986 | 0.090 |
Why?
|
Cisplatin | 1 | 2016 | 1644 | 0.090 |
Why?
|
Medical Informatics | 1 | 2017 | 732 | 0.090 |
Why?
|
Infant, Premature | 2 | 2016 | 2092 | 0.080 |
Why?
|
Premature Birth | 1 | 2021 | 1771 | 0.080 |
Why?
|
Research | 1 | 2018 | 1974 | 0.080 |
Why?
|
Aged | 9 | 2021 | 169152 | 0.080 |
Why?
|
Cell Cycle | 1 | 2017 | 2934 | 0.080 |
Why?
|
Immunohistochemistry | 2 | 2021 | 11071 | 0.080 |
Why?
|
Bariatric Surgery | 1 | 2019 | 1005 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4283 | 0.080 |
Why?
|
Information Dissemination | 1 | 2017 | 1131 | 0.080 |
Why?
|
Colorectal Neoplasms | 2 | 2022 | 6853 | 0.080 |
Why?
|
Suicide | 1 | 2019 | 1599 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6544 | 0.070 |
Why?
|
Myocytes, Cardiac | 1 | 2016 | 1657 | 0.070 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2013 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2250 | 0.070 |
Why?
|
Male | 13 | 2021 | 359744 | 0.070 |
Why?
|
Diagnostic Imaging | 1 | 2020 | 3527 | 0.070 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2696 | 0.070 |
Why?
|
Glioblastoma | 1 | 2021 | 3484 | 0.070 |
Why?
|
Decision Making | 1 | 2019 | 3925 | 0.060 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20080 | 0.060 |
Why?
|
Biomedical Research | 1 | 2021 | 3426 | 0.060 |
Why?
|
Adolescent | 4 | 2022 | 87810 | 0.060 |
Why?
|
Telemedicine | 1 | 2022 | 3018 | 0.060 |
Why?
|
Research Design | 1 | 2021 | 6180 | 0.060 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2016 | 1846 | 0.060 |
Why?
|
Nurses | 1 | 2014 | 2467 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 2 | 2021 | 36290 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5697 | 0.050 |
Why?
|
Risk Assessment | 2 | 2021 | 24123 | 0.050 |
Why?
|
China | 2 | 2021 | 2339 | 0.050 |
Why?
|
Taiwan | 2 | 2014 | 505 | 0.050 |
Why?
|
Apgar Score | 1 | 2021 | 126 | 0.050 |
Why?
|
United States | 5 | 2021 | 72461 | 0.050 |
Why?
|
Genetic Variation | 1 | 2016 | 6551 | 0.050 |
Why?
|
Students, Medical | 1 | 2014 | 1927 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9411 | 0.040 |
Why?
|
Genomics | 1 | 2016 | 5794 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15289 | 0.040 |
Why?
|
Genome-Wide Association Study | 2 | 2016 | 12626 | 0.040 |
Why?
|
Child | 4 | 2022 | 79806 | 0.040 |
Why?
|
Depression | 1 | 2019 | 8044 | 0.040 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2020 | 253 | 0.040 |
Why?
|
Infant | 2 | 2018 | 36060 | 0.040 |
Why?
|
Young Adult | 3 | 2021 | 58741 | 0.040 |
Why?
|
Adult | 7 | 2021 | 219994 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15789 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2019 | 15697 | 0.030 |
Why?
|
Hearing | 1 | 2020 | 501 | 0.030 |
Why?
|
Inverted Repeat Sequences | 1 | 2016 | 61 | 0.030 |
Why?
|
Public Health Informatics | 1 | 2017 | 109 | 0.030 |
Why?
|
Physicians | 1 | 2014 | 4591 | 0.030 |
Why?
|
Child, Preschool | 1 | 2018 | 42063 | 0.030 |
Why?
|
Prospective Studies | 2 | 2019 | 54303 | 0.030 |
Why?
|
Chromosomal Instability | 1 | 2016 | 177 | 0.030 |
Why?
|
Ethics, Nursing | 1 | 2014 | 24 | 0.030 |
Why?
|
Blood Specimen Collection | 1 | 2015 | 238 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2011 | 7850 | 0.030 |
Why?
|
Haploinsufficiency | 1 | 2015 | 329 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1062 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13630 | 0.030 |
Why?
|
Brain | 1 | 2020 | 26951 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2016 | 65017 | 0.030 |
Why?
|
Altruism | 1 | 2014 | 205 | 0.030 |
Why?
|
Gene Dosage | 1 | 2016 | 1218 | 0.020 |
Why?
|
Forecasting | 1 | 2021 | 2932 | 0.020 |
Why?
|
Cities | 1 | 2014 | 538 | 0.020 |
Why?
|
Incidence | 2 | 2021 | 21392 | 0.020 |
Why?
|
Annexin A4 | 1 | 2011 | 9 | 0.020 |
Why?
|
Social Responsibility | 1 | 2014 | 386 | 0.020 |
Why?
|
alpha-Defensins | 1 | 2011 | 30 | 0.020 |
Why?
|
Cell Death | 1 | 2016 | 1672 | 0.020 |
Why?
|
Neonatal Screening | 1 | 2015 | 595 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1745 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2014 | 633 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2021 | 22053 | 0.020 |
Why?
|
Carcinoembryonic Antigen | 1 | 2011 | 336 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2192 | 0.020 |
Why?
|
Ethics, Medical | 1 | 2014 | 783 | 0.020 |
Why?
|
Models, Educational | 1 | 2011 | 373 | 0.020 |
Why?
|
Developed Countries | 1 | 2011 | 442 | 0.020 |
Why?
|
Professional Role | 1 | 2011 | 310 | 0.020 |
Why?
|
Animals | 2 | 2018 | 167963 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2022 | 7806 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2016 | 1974 | 0.020 |
Why?
|
Immunosuppressive Agents | 1 | 2021 | 4166 | 0.020 |
Why?
|
Patient Participation | 1 | 2017 | 1439 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2021 | 80372 | 0.020 |
Why?
|
Logistic Models | 1 | 2022 | 13314 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2016 | 2440 | 0.020 |
Why?
|
DNA Repair | 1 | 2016 | 2039 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2013 | 2698 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 12965 | 0.020 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2011 | 611 | 0.020 |
Why?
|
Blood Proteins | 1 | 2011 | 1173 | 0.020 |
Why?
|
Databases, Factual | 1 | 2021 | 8035 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10547 | 0.020 |
Why?
|
Societies, Medical | 1 | 2017 | 3905 | 0.020 |
Why?
|
Diet | 1 | 2022 | 8010 | 0.010 |
Why?
|
Tandem Mass Spectrometry | 1 | 2011 | 1189 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 4713 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2016 | 3811 | 0.010 |
Why?
|
Risk Factors | 2 | 2021 | 74359 | 0.010 |
Why?
|
Survival Analysis | 1 | 2016 | 10182 | 0.010 |
Why?
|
Genome, Human | 1 | 2016 | 4417 | 0.010 |
Why?
|
Pandemics | 1 | 2022 | 8624 | 0.010 |
Why?
|
Health Promotion | 1 | 2014 | 2206 | 0.010 |
Why?
|
Consensus | 1 | 2011 | 3113 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58995 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2022 | 39261 | 0.010 |
Why?
|
Communication | 1 | 2014 | 3849 | 0.010 |
Why?
|
Education, Medical | 1 | 2011 | 1727 | 0.010 |
Why?
|
Pregnancy | 1 | 2021 | 29749 | 0.010 |
Why?
|
Time Factors | 1 | 2021 | 40165 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2011 | 13451 | 0.010 |
Why?
|
Developing Countries | 1 | 2011 | 2868 | 0.010 |
Why?
|
Peptides | 1 | 2011 | 4354 | 0.010 |
Why?
|
Clinical Competence | 1 | 2014 | 4783 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12159 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12531 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2011 | 8515 | 0.010 |
Why?
|
Mice | 1 | 2015 | 81208 | 0.000 |
Why?
|